
Delta 9 Cannabis Inc
TSX:DN

Net Margin
Delta 9 Cannabis Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
CA |
![]() |
Delta 9 Cannabis Inc
TSX:DN
|
3.5m CAD |
-28%
|
|
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
731.4B USD |
23%
|
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP |
-4%
|
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
393.8B USD |
25%
|
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
35%
|
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
205.6B CHF |
14%
|
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
180.8B CHF |
24%
|
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
159.6B GBP |
14%
|
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
201.2B USD |
27%
|
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD |
-126%
|
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
139.1B USD |
13%
|
Delta 9 Cannabis Inc
Glance View
Delta 9 Cannabis, Inc. is a vertically integrated cannabis company, which engages in the production of medical and recreational cannabis products. The company is headquartered in Winnipeg, Manitoba and currently employs 210 full-time employees. The company went IPO on 2004-03-31. The firm operates through three segments: Wholesale Cannabis, Retail Cannabis and Merchandise and Devices and Grow Pods. The Company, through its wholly owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis products and operates an 80,000 square foot Health Canada licensed production facility in Winnipeg, Manitoba, Canada. The company owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. The firm also operates a business to business, selling Grow Pods, Cannabis genetics, and providing consulting and licensing services to other cannabis businesses. The firm sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. The company operates 12 cannabis retail stores with an additional eight retail outlet stores in jurisdictions.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Delta 9 Cannabis Inc's most recent financial statements, the company has Net Margin of -27.7%.